Response to ‘Pervasive Sequence Patents Cover the Entire Human Genome’
- Author(s):
- Shine Tu, Christopher M. Holman, Adam Mossoff, Ted M. Sichelman, Michael Risch, Jorge L. Contreras, Yaniv Heled, Gregory Dolin, Lee Petherbridge
- Posted:
- 3-2014
- Law & Economics #:
- 14-07
- Availability:
- Full text (most recent) on SSRN
ABSTRACT:
In a widely reported article by Jeffrey Rosenfeld and Christopher Mason published in Genome Medicine, significant misstatements were made, because the authors did not sufficiently review the claims - which define the legal scope of a patent - in the patents they analyzed. Specifically, the authors do not provide an adequate basis for their assertion that 41% of the genes in the human genome have been claimed.